Trial · NCT01669421
Results by group63
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 63
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | IL-2 | 14.3 | Standard Deviation 7.3 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | IL-2 | 8.1 | Standard Deviation 3.1 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose | IL-2 | 10.3 | Standard Deviation 1.7 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | IL-8 | 379.9 | Standard Deviation 294.3 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | IL-8 | 563.2 | Standard Deviation 317.8 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose | IL-8 | 412.2 | Standard Deviation 160.1 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | IL-17 | 79.0 | Standard Deviation 27.8 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | IL-17 | 61.5 | Standard Deviation 15.8 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose | IL-17 | 67.4 | Standard Deviation 8.5 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | BASIC FGF | 20.7 | Standard Deviation 9.3 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | BASIC FGF | 15.4 | Standard Deviation 4.3 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose | BASIC FGF | 16.5 | Standard Deviation 2.1 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | GM-CSF | 114.9 | Standard Deviation 36.2 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | GM-CSF | 89.1 | Standard Deviation 33.6 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose | GM-CSF | 105.4 | Standard Deviation 20.8 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | IL-15 | 116.5 | Standard Deviation 68.4 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | IL-15 | 92.5 | Standard Deviation 38.9 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose | IL-15 | 90.5 | Standard Deviation 16.6 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Standard Dose Baseline | IL1alpha | 30.7 | Standard Deviation 18.7 | pg/ml |
| Changes in Inflammatory Biomarkers in Bronchoalveolar Lavage Fluid | Alpha-1 Antitrypsin (Human) Double Dose | IL1alpha | 27.4 | Standard Deviation 18.8 | pg/ml |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01669421/results